U.S. prosecutors on Tuesday announced insider trading charges accusing the former chief executive of Auspex Pharmaceuticals Inc with tipping friends and family about an anticipated tender offer for his company by Teva Pharmaceutical Industries Ltd in 2015.
What happened
Shares of remote-restraint device company Wrap Technologies (NASDAQ: WRTC) spiked higher on Tuesday, after this kind of technology was highlighted by a speaker at the Republican National Convention (RNC). While Wrap Technologies' flagship product, the BolaWrap, was
In this episode of Motley Fool Money, Chris Hill chats with Motley Fool analysts, Jason Moser and Ron Gross, about the latest headlines from Wall Street. They discuss the big gains in the retail sector, a big decision for ridesharing companies and a big number for Apple (NASDAQ:
Northern Dynasty Minerals Ltd shares fell more than 30% on Tuesday on rising doubts the company can clear regulatory hurdles for its Pebble Mine project in Alaska, and prominent politicians said it would harm the state's salmon fishing industry.
The collapsed payments company Wirecard has let go more than half of its remaining staff in Germany and terminated the contracts of its management board members, its insolvency administrator said.
What happened?
Shares of Orchard Therapeutics (NASDAQ: ORTX) are up by 16.9% as of 12:27 p.m. EDT on Tuesday after rising by as much as 32.9% earlier today. The biotech company did not report any news that served as a catalyst for these massive gains, though, so what gives?
Snowflake, a cloud data management company, filed a preliminary S-1 with the Securities and Exchange Commission (SEC) yesterday in preparation for its initial public offering (IPO). It plans to trade on the New York Stock Exchange using the ticker symbol "SNOW." Since this is th
A South African court ruled on Tuesday that a Kuwaiti firm could ship thousands of sheep to the Middle East, dealing a blow to animal welfare activists seeking to ban such exports on concerns that extreme heat could kill the animals en route.
The Botswana government said there was no guarantee that it would be able to renew a new 10-year sales agreement with De Beers before the end of December, when the current one expires, as the coronavirus pandemic has delayed negotiations.
The South African rand extended gains against the dollar on Tuesday, as riskier currencies forged ahead after positive signals from trade talks between the United States and China.
Canada is the only member of the Five Eyes intelligence-sharing network that has not formally blocked Huawei from 5G networks, but it has effectively done just that, delaying a decision long enough to force telecom companies to exclude the Chinese gear maker.
Brazilian food producer Central Cooperativa Aurora has voluntarily suspended poultry exports to China from one of its plants starting Aug. 20, the Chinese customs authority's website showed on Tuesday.
The president of the U.N. Security Council, Indonesia, said on Tuesday it was "not in the position to take further action" on a U.S. bid to trigger a return of all U.N. sanctions on Iran because there is no consensus in the 15-member body.
Northern Dynasty Minerals Ltd shares fell more than 25% on Tuesday on rising doubts the company can clear regulatory hurdles for its Pebble Mine project in Alaska, and prominent politicians said it would harm the state's salmon fishing industry.
Boeing Co said on Tuesday it aims to redo its unmanned Starliner crew capsule flight test to the International Space Station (ISS) in December or January, depending on when it completes software and test hardware production development.
American Airlines Group (NASDAQ: AAL) said on Tuesday that it expects at least 40,000 job cuts in early October, including about 19,000 involuntary furloughs, as the airline braces for falling demand and begins to adjust to life without government payroll support.
The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.